These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 27427223)
1. Effect of tumor location on survival in urinary bladder adenocarcinoma: A population-based analysis. Dutta R; Abdelhalim A; Martin JW; Vernez SL; Faltas B; Lotan Y; Youssef RF Urol Oncol; 2016 Dec; 34(12):531.e1-531.e6. PubMed ID: 27427223 [TBL] [Abstract][Full Text] [Related]
2. Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas. Zhou YW; Long YX; Song K; Liang LB; Cheng K; Chen Y; Liu JY Cancer Med; 2021 Aug; 10(16):5415-5428. PubMed ID: 34278741 [TBL] [Abstract][Full Text] [Related]
3. Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study. Natale C; Leinwand GZ; Chiang J; Silberstein JL; Krane LS Clin Genitourin Cancer; 2019 Oct; 17(5):380-388. PubMed ID: 31395362 [TBL] [Abstract][Full Text] [Related]
4. Malignant urachal neoplasms: A population-based study and systematic review of literature. Mylonas KS; O Malley P; Ziogas IA; El-Kabab L; Nasioudis D Urol Oncol; 2017 Jan; 35(1):33.e11-33.e19. PubMed ID: 27592530 [TBL] [Abstract][Full Text] [Related]
5. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Wright JL; Porter MP; Li CI; Lange PH; Lin DW Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584 [TBL] [Abstract][Full Text] [Related]
6. The demographic features, clinicopathologic characteristics, treatment outcome and disease-specific prognostic factors of solitary fibrous tumor: a population-based analysis. Wushou A; Jiang YZ; Liu YR; Shao ZM Oncotarget; 2015 Dec; 6(39):41875-83. PubMed ID: 26496033 [TBL] [Abstract][Full Text] [Related]
7. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment? Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580 [TBL] [Abstract][Full Text] [Related]
8. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database. Schneiderman BA; Kliethermes SA; Nystrom LM Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Indicators in Base of Tongue Adenocarcinoma: A Population-Based Analysis. Kraimer K; Ganti A; Plitt MA; Revenaugh P; Stenson K; Tajudeen BA; Al-Khudari S Ear Nose Throat J; 2021 Sep; 100(5_suppl):467S-471S. PubMed ID: 31619077 [TBL] [Abstract][Full Text] [Related]
10. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location. Golan T; Urban D; Berger R; Lawrence YR Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150 [TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 14 cases of urachal carcinoma]. Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037 [TBL] [Abstract][Full Text] [Related]
12. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine. Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382 [TBL] [Abstract][Full Text] [Related]
13. Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database. Davaro F; Schaefer J; May A; Raza J; Siddiqui S; Hamilton Z World J Urol; 2019 Mar; 37(3):497-505. PubMed ID: 30030660 [TBL] [Abstract][Full Text] [Related]
14. Predicting survival for well-differentiated liposarcoma: the importance of tumor location. Smith CA; Martinez SR; Tseng WH; Tamurian RM; Bold RJ; Borys D; Canter RJ J Surg Res; 2012 Jun; 175(1):12-7. PubMed ID: 21920555 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology, Prognostic Factors, and Treatment of Malignant Submandibular Gland Tumors: A Population-Based Cohort Analysis. Lee RJ; Tan AP; Tong EL; Satyadev N; Christensen RE JAMA Otolaryngol Head Neck Surg; 2015 Oct; 141(10):905-12. PubMed ID: 26378411 [TBL] [Abstract][Full Text] [Related]
16. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases. Lee KC; Chuang SK; Philipone EM; Peters SM Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539 [TBL] [Abstract][Full Text] [Related]
17. Analysis of bladder carcinoma by subsite. Cystoscopic location may have prognostic value. Stephenson WT; Holmes FF; Noble MJ; Gerald KB Cancer; 1990 Oct; 66(7):1630-5. PubMed ID: 2208014 [TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality. Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis. Lee IJ; Lee RJ; Fahim DK World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925 [TBL] [Abstract][Full Text] [Related]
20. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma. Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]